dronabinol

FDA Drug Profile — DRONABINOL

Drug Details

Generic Name
dronabinol
Brand Names
DRONABINOL
Application Number
ANDA207421
Sponsor
Camber Pharmaceuticals Inc
NDC Codes
4
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
DRONABINOL

Indications and Usage

1 INDICATIONS AND USAGE DRONABINOL CAPSULES, USP are indicated in adults for the treatment of: anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS). nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. Dronabinol capsules are a cannabinoid indicated in adults for the treatment of: Anorexia associated with weight loss in patients with AIDS. ( 1 ) Nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. ( 1 )